U.S. flag

An official website of the United States government

NM_000243.3(MEFV):c.540G>C (p.Pro180=) AND not specified

Germline classification:
Likely benign (2 submissions)
Last evaluated:
Dec 24, 2018
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000610894.2

Allele description [Variation Report for NM_000243.3(MEFV):c.540G>C (p.Pro180=)]

NM_000243.3(MEFV):c.540G>C (p.Pro180=)

Gene:
MEFV:MEFV innate immunity regulator, pyrin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
16p13.3
Genomic location:
Preferred name:
NM_000243.3(MEFV):c.540G>C (p.Pro180=)
HGVS:
  • NC_000016.10:g.3254528C>G
  • NG_007871.1:g.7100G>C
  • NM_000243.3:c.540G>CMANE SELECT
  • NM_001198536.2:c.277+1783G>C
  • NP_000234.1:p.Pro180=
  • NP_000234.1:p.Pro180=
  • LRG_190t1:c.540G>C
  • LRG_190:g.7100G>C
  • LRG_190p1:p.Pro180=
  • NC_000016.9:g.3304528C>G
  • NM_000243.1:c.540G>C
  • NM_000243.2:c.540G>C
Links:
dbSNP: rs104895139
NCBI 1000 Genomes Browser:
rs104895139
Molecular consequence:
  • NM_001198536.2:c.277+1783G>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000243.3:c.540G>C - synonymous variant - [Sequence Ontology: SO:0001819]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000714350GeneDx
criteria provided, single submitter

(GeneDx Variant Classification (06012015))
Likely benign
(Apr 18, 2017)
germlineclinical testing

Citation Link,

SCV000919632Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Likely benign
(Dec 24, 2018)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Is There a Long-Term Risk for Donors With Heterozygous MEFV Mutation After Kidney Donation?

Karakose S, Erdogmus S, Akturk S, Tuzuner A, Sengul S, Keven K.

Transplant Proc. 2017 Apr;49(3):399-402. doi: 10.1016/j.transproceed.2017.01.012.

PubMed [citation]
PMID:
28340799

Comprehensive analysis of a large-scale screen for MEFV gene mutations: do they truly provide a "heterozygote advantage" in Turkey?

Berdeli A, Mir S, Nalbantoglu S, Kutukculer N, Sozeri B, Kabasakal Y, Cam S, Solak M.

Genet Test Mol Biomarkers. 2011 Jul-Aug;15(7-8):475-82. doi: 10.1089/gtmb.2010.0146. Epub 2011 Mar 17.

PubMed [citation]
PMID:
21413889
See all PubMed Citations (3)

Details of each submission

From GeneDx, SCV000714350.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV000919632.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

Variant summary: MEFV c.540G>C results in a synonymous change. 5/5 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 6.6e-06 in 150946 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. Though c.540G>C has been reported in the literature in some Turkish individuals affected with Familial Mediterranean Fever, authors listed the variant as a polymorphism (Berdeli 2011, Nalbantoglu 2013). In addition, co-occurrences with two other pathogenic variants have been reported in patients (Infever database: MEFV p.Met694Val / p.Met694Val and p.Met694Val / p.Val726Ala), and co-occurrence with another pathogenic MEFV variant (p.Met694Val) was also reported in an asymptomatic individual (Karakose 2017), providing supporting evidence for a benign role. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation, and classified the variant as likely benign. Based on the evidence outlined above, the variant was classified as likely benign.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 20, 2024